QURE
uniQure (QURE)
$51
About uniQure (QURE)
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
Details
Daily high
$20.00
Daily low
$19.34
Price at open
$19.87
52 Week High
$71.50
52 Week Low
$7.76
Market cap
1.2B
Dividend yield
0.00%
Volume
10,673
Avg. volume
2.5M
P/E ratio
-4.45
uniQure News
Details
Daily high
$20.00
Daily low
$19.34
Price at open
$19.87
52 Week High
$71.50
52 Week Low
$7.76
Market cap
1.2B
Dividend yield
0.00%
Volume
10,673
Avg. volume
2.5M
P/E ratio
-4.45